| Original language | English (US) |
|---|---|
| Pages (from-to) | 1529-1533 |
| Number of pages | 5 |
| Journal | Journal of the American Academy of Dermatology |
| Volume | 83 |
| Issue number | 5 |
| DOIs | |
| State | Published - Nov 2020 |
ASJC Scopus subject areas
- Dermatology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Intranasal butorphanol rescue therapy for the treatment of intractable pruritus : A case series from the Johns Hopkins Itch Clinic. / Khanna, Raveena; Kwon, Christina D.; Patel, Sagar P.; Belzberg, Micah; Williams, Kyle A.; Khanna, Ramona; Boozalis, Emily; Kwatra, Shawn G.
In: Journal of the American Academy of Dermatology, Vol. 83, No. 5, 11.2020, p. 1529-1533.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Intranasal butorphanol rescue therapy for the treatment of intractable pruritus
T2 - A case series from the Johns Hopkins Itch Clinic
AU - Khanna, Raveena
AU - Kwon, Christina D.
AU - Patel, Sagar P.
AU - Belzberg, Micah
AU - Williams, Kyle A.
AU - Khanna, Ramona
AU - Boozalis, Emily
AU - Kwatra, Shawn G.
N1 - Funding Information: Funding sources: Dr Kwatra has received the Dermatology Foundation Medical Dermatology Career Development Award. Funding Information: Conflicts of interest: Dr Kwatra is on the scientific advisory board for Incyte Corporation, Pfizer Inc , Regeneron Pharmaceuticals , and Menlo Therapeutics and has received grant funding from Galderma SA, Kiniksa Pharmaceuticals , and Pfizer Inc . Authors Khanna, Khanna, and Williams and Drs Kwon, Patel, Belzberg and Boozalis have no conflicts of interest to declare. Funding Information: Funding sources: Dr Kwatra has received the Dermatology Foundation Medical Dermatology Career Development Award.Conflicts of interest: Dr Kwatra is on the scientific advisory board for Incyte Corporation, Pfizer Inc, Regeneron Pharmaceuticals, and Menlo Therapeutics and has received grant funding from Galderma SA, Kiniksa Pharmaceuticals, and Pfizer Inc. Authors Khanna, Khanna, and Williams and Drs Kwon, Patel, Belzberg and Boozalis have no conflicts of interest to declare.IRB approval status: Approval was granted by the Johns Hopkins Medicine Institutional Review Board. Patient consent was not required.
PY - 2020/11
Y1 - 2020/11
UR - http://www.scopus.com/inward/record.url?scp=85090933015&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090933015&partnerID=8YFLogxK
U2 - 10.1016/j.jaad.2020.07.017
DO - 10.1016/j.jaad.2020.07.017
M3 - Article
C2 - 32679280
AN - SCOPUS:85090933015
VL - 83
SP - 1529
EP - 1533
JO - Journal of the American Academy of Dermatology
JF - Journal of the American Academy of Dermatology
SN - 0190-9622
IS - 5
ER -